Skip to content

NovoCure NVCR Operating margin

Operating margin at other companies

Boston Scientific logo
Boston ScientificBSX
18.4%+2.2pp
Medtronic logo
MedtronicMDT
17.8%0.0pp
Iovance Biotherapeutics, Inc. logo
Iovance Biotherapeutics, Inc.IOVA
-127.2%-31.0pp
Nuvation Bio logo
Nuvation BioNUVB
-105%-52.0pp
Vir Biotechnology, Inc. logo
Vir Biotechnology, Inc.VIR
-720.8%-313pp
Syndax Pharmaceuticals logo
Syndax PharmaceuticalsSNDX
-102.8%-47.8pp

Other financials

Income statement

See full
Revenue$174.1M+12.3%
Gross profit$135.1M+16.0%
Operating income-$67.4M-78.1%
Net income-$71.1M-107%
EPS (diluted)-$0.62-100%

Balance sheet

See full
Cash & equivalents$87.5M-31.2%
Total debt$39.5M-2.1%
Total equity$330.7M-8.6%
Total assets$787.9M-36.9%

Cash flow

See full
Operating cash flow-$13.5M+62.1%
CapEx$5.2M-51.4%
Free cash flow-$18.7M+59.7%

Valuation

See full
Market cap$1.64B-36.7%
Enterprise value$1.59B-36.3%
P/S2.4×-1.7×

Profitability

See full
Gross margin75.2%-2.0pp
Net margin-25.7%-0.7pp
FCF margin-7.1%-2.0pp

Returns & leverage

See full
Return on equity-50%+5.4pp
Debt / equity0.1×0.0×
Current ratio2.9×+1.4×

Where this comes from

Calculated from NovoCure’s reported figures.

Based on trailing twelve months.

The official record: NovoCure’s 10-Q, filed April 30, 2026, on SEC EDGAR. View the filing →

Ask your AI about NovoCure's operating margin.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is NovoCure's operating margin?
NovoCure (NVCR) reported operating margin of -27.2% in Q1 2026.
How has NovoCure's operating margin changed year-over-year?
NovoCure's operating margin decreased by 1.3% year-over-year, from -26.8% to -27.2%.
What is the long-term trend for NovoCure's operating margin?
Over 5 years (2020 to 2025), NovoCure's operating margin has grown at a 30.7% compound annual growth rate (CAGR), from 6.1% to -23.5%.
What does operating margin mean?
Operating income as a percentage of revenue (trailing twelve months). Captures profitability from core operations after both cost of revenue and operating expenses, but before interest and taxes.